Nova Historical Balance Sheet

EYE Stock

0.15 0.01 6.25%

Trend analysis of Nova Eye Medical balance sheet accounts such as Other Current Liabilities of 2.7 M or Total Current Liabilities of 9.4 M provides information on Nova Eye's total assets, liabilities, and equity, which is the actual value of Nova Eye Medical to its prevalent stockholders. By breaking down trends over time using Nova Eye balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Nova Eye Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Nova Eye Medical is a good buy for the upcoming year.

Nova Eye Inventory

4.07 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Nova Eye Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Nova Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Nova Eye Medical at a specified time, usually calculated after every quarter, six months, or one year. Nova Eye Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nova Eye and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nova currently owns. An asset can also be divided into two categories, current and non-current.

Nova Eye Balance Sheet Chart

At this time, Nova Eye's Net Receivables is comparatively stable compared to the past year. Common Stock Total Equity is likely to gain to about 94.6 M in 2024, despite the fact that Net Debt is likely to grow to (2.7 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Nova Eye assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Nova Eye Medical books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Nova Eye balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Nova Eye Medical are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Nova Eye's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Nova Eye Medical current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Nova Eye Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	1.9M	1.5M	3.3M	3.2M
Total Assets	36.6M	30.4M	29.9M	40.5M

Short Long Term Debt Total Total Assets

Nova Eye balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Other Current Assets
Total Assets		0.71	0.52	0.82	0.98	0.63	0.82	-0.48	0.62	0.52	0.64	0.32	-0.42	0.64	0.62	0.24	-0.2	0.33	0.64	-0.38	0.84	0.73	0.95	0.66	0.89	-0.07
Short Long Term Debt Total	0.71		0.79	0.92	0.56	0.92	0.33	0.24	0.24	0.46	-0.03	0.31	-0.27	-0.03	0.88	-0.01	-0.37	0.38	0.95	0.3	0.94	0.9	0.48	0.95	0.61	-0.05
Other Current Liab	0.52	0.79		0.71	0.36	0.69	0.15	0.34	0.18	0.18	-0.18	0.08	-0.21	-0.18	0.86	-0.16	-0.43	0.41	0.82	0.42	0.8	0.7	0.3	0.66	0.36	-0.03
Total Current Liabilities	0.82	0.92	0.71		0.69	0.79	0.48	0.05	0.34	0.68	0.15	0.17	-0.36	0.15	0.89	0.03	-0.32	0.14	0.92	0.14	0.98	0.86	0.64	0.94	0.69	-0.13
Total Stockholder Equity	0.98	0.56	0.36	0.69		0.5	0.88	-0.65	0.68	0.44	0.79	0.34	-0.41	0.79	0.45	0.31	-0.13	0.32	0.46	-0.56	0.7	0.61	0.99	0.51	0.88	-0.05
Property Plant And Equipment Net	0.63	0.92	0.69	0.79	0.5		0.31	0.21	0.1	0.3	-0.02	0.51	-0.16	-0.02	0.74	0.11	-0.17	0.55	0.83	0.3	0.82	0.86	0.42	0.82	0.6	-0.13
Current Deferred Revenue	0.82	0.33	0.15	0.48	0.88	0.31		-0.75	0.61	0.28	0.85	0.13	-0.27	0.85	0.24	0.13	-0.11	0.21	0.25	-0.62	0.48	0.33	0.91	0.3	0.78	-0.35
Net Debt	-0.48	0.24	0.34	0.05	-0.65	0.21	-0.75		-0.56	-0.03	-0.98	-0.11	0.15	-0.98	0.33	-0.34	-0.21	-0.04	0.36	0.94	0.07	0.13	-0.71	0.25	-0.49	0.08
Retained Earnings	0.62	0.24	0.18	0.34	0.68	0.1	0.61	-0.56		0.07	0.62	-0.01	-0.43	0.62	0.25	-0.29	-0.62	-0.01	0.23	-0.65	0.35	0.22	0.7	0.27	0.33	0.3
Accounts Payable	0.52	0.46	0.18	0.68	0.44	0.3	0.28	-0.03	0.07		0.13	0.07	-0.38	0.13	0.51	0.27	0.01	-0.21	0.53	0.05	0.61	0.54	0.41	0.57	0.55	-0.03
Cash	0.64	-0.03	-0.18	0.15	0.79	-0.02	0.85	-0.98	0.62	0.13		0.18	-0.2	1.0	-0.15	0.35	0.14	0.13	-0.16	-0.91	0.13	0.05	0.84	-0.05	0.63	-0.1
Non Current Assets Total	0.32	0.31	0.08	0.17	0.34	0.51	0.13	-0.11	-0.01	0.07	0.18		-0.17	0.18	0.05	0.62	0.23	0.68	0.15	-0.15	0.22	0.46	0.23	0.17	0.45	0.19
Non Currrent Assets Other	-0.42	-0.27	-0.21	-0.36	-0.41	-0.16	-0.27	0.15	-0.43	-0.38	-0.2	-0.17		-0.2	-0.2	-0.09	0.3	0.14	-0.33	0.2	-0.35	-0.52	-0.34	-0.37	-0.4	-0.5
Cash And Short Term Investments	0.64	-0.03	-0.18	0.15	0.79	-0.02	0.85	-0.98	0.62	0.13	1.0	0.18	-0.2		-0.15	0.35	0.14	0.13	-0.16	-0.91	0.13	0.05	0.84	-0.05	0.63	-0.1
Net Receivables	0.62	0.88	0.86	0.89	0.45	0.74	0.24	0.33	0.25	0.51	-0.15	0.05	-0.2	-0.15		-0.21	-0.49	0.21	0.96	0.4	0.93	0.75	0.4	0.85	0.43	-0.1
Common Stock Total Equity	0.24	-0.01	-0.16	0.03	0.31	0.11	0.13	-0.34	-0.29	0.27	0.35	0.62	-0.09	0.35	-0.21		0.78	0.37	-0.17	-0.29	0.03	0.25	0.25	-0.11	0.49	0.06
Common Stock Shares Outstanding	-0.2	-0.37	-0.43	-0.32	-0.13	-0.17	-0.11	-0.21	-0.62	0.01	0.14	0.23	0.3	0.14	-0.49	0.78		0.06	-0.49	-0.1	-0.34	-0.16	-0.13	-0.4	0.1	-0.27
Non Current Liabilities Total	0.33	0.38	0.41	0.14	0.32	0.55	0.21	-0.04	-0.01	-0.21	0.13	0.68	0.14	0.13	0.21	0.37	0.06		0.22	0.0	0.28	0.39	0.24	0.08	0.42	0.01
Inventory	0.64	0.95	0.82	0.92	0.46	0.83	0.25	0.36	0.23	0.53	-0.16	0.15	-0.33	-0.16	0.96	-0.17	-0.49	0.22		0.41	0.94	0.85	0.39	0.93	0.5	-0.05
Other Stockholder Equity	-0.38	0.3	0.42	0.14	-0.56	0.3	-0.62	0.94	-0.65	0.05	-0.91	-0.15	0.2	-0.91	0.4	-0.29	-0.1	0.0	0.41		0.16	0.16	-0.62	0.28	-0.33	-0.15
Total Liab	0.84	0.94	0.8	0.98	0.7	0.82	0.48	0.07	0.35	0.61	0.13	0.22	-0.35	0.13	0.93	0.03	-0.34	0.28	0.94	0.16		0.88	0.65	0.9	0.71	-0.1
Property Plant And Equipment Gross	0.73	0.9	0.7	0.86	0.61	0.86	0.33	0.13	0.22	0.54	0.05	0.46	-0.52	0.05	0.75	0.25	-0.16	0.39	0.85	0.16	0.88		0.5	0.85	0.71	0.13
Total Current Assets	0.95	0.48	0.3	0.64	0.99	0.42	0.91	-0.71	0.7	0.41	0.84	0.23	-0.34	0.84	0.4	0.25	-0.13	0.24	0.39	-0.62	0.65	0.5		0.45	0.84	-0.11
Short Term Debt	0.66	0.95	0.66	0.94	0.51	0.82	0.3	0.25	0.27	0.57	-0.05	0.17	-0.37	-0.05	0.85	-0.11	-0.4	0.08	0.93	0.28	0.9	0.85	0.45		0.54	-0.05
Common Stock	0.89	0.61	0.36	0.69	0.88	0.6	0.78	-0.49	0.33	0.55	0.63	0.45	-0.4	0.63	0.43	0.49	0.1	0.42	0.5	-0.33	0.71	0.71	0.84	0.54		-0.17
Other Current Assets	-0.07	-0.05	-0.03	-0.13	-0.05	-0.13	-0.35	0.08	0.3	-0.03	-0.1	0.19	-0.5	-0.1	-0.1	0.06	-0.27	0.01	-0.05	-0.15	-0.1	0.13	-0.11	-0.05	-0.17

Click cells to compare fundamentals

Nova Eye Account Relationship Matchups

Nova Eye balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	116.7M	42.0M	36.6M	30.4M	29.9M	40.5M
Short Long Term Debt Total	3.3M	3.7M	1.9M	1.5M	3.3M	3.2M
Other Current Liab	472K	746K	912K	1.3M	1.6M	2.7M
Total Current Liabilities	14.4M	4.7M	3.9M	6.3M	5.7M	9.4M
Total Stockholder Equity	100.6M	35.3M	30.4M	23.2M	21.3M	29.1M
Property Plant And Equipment Net	2.9M	3.5M	2.9M	2.4M	3.9M	4.4M
Current Deferred Revenue	8.2M	(1.9M)	1.0	(639K)	(734.9K)	(698.1K)
Net Debt	(92.3M)	(14.1M)	(6.1M)	(5.9M)	(2.8M)	(2.7M)
Retained Earnings	24.6M	892K	(6.6M)	(21.9M)	(30.7M)	(29.2M)
Accounts Payable	3.8M	2.0M	2.4M	4.3M	3.6M	2.8M
Cash	95.6M	17.8M	8M	7.4M	6.2M	6.6M
Non Current Assets Total	13.8M	15.7M	21.0M	15.8M	15.1M	13.4M
Non Currrent Assets Other	(6.3M)	(6.9M)	(10.1M)	(10.8M)	4.2M	4.4M
Cash And Short Term Investments	95.6M	17.8M	8M	7.4M	6.2M	6.6M
Net Receivables	3.8M	1.9M	2.0M	1.9M	4.1M	6.4M
Liabilities And Stockholders Equity	116.7M	42.0M	36.6M	30.4M	29.9M	40.5M
Non Current Liabilities Total	1.8M	2.0M	2.4M	892K	2.9M	2.1M
Inventory	2.9M	2.9M	3.5M	3.8M	4.3M	4.1M
Other Stockholder Equity	(102.9M)	(37.6M)	(30.8M)	(1.0)	(0.9)	(0.94)
Total Liab	16.2M	6.7M	6.2M	7.2M	8.6M	11.4M
Property Plant And Equipment Gross	10.4M	13.1M	15.2M	9.2M	10.4M	8.7M
Total Current Assets	102.9M	26.3M	15.6M	14.6M	14.7M	22.8M
Accumulated Other Comprehensive Income	(2.4M)	(2.2M)	(439K)	(87.0K)	(693K)	(658.4K)
Short Term Debt	1.9M	1.9M	544K	639K	480K	456K
Other Current Assets	494K	3.7M	2.0M	1.4M	234K	222.3K
Intangible Assets	10.9M	12.1M	18.0M	13.3M	7.0M	6.8M
Other Assets	7.6M	8.7M	10.9M	4.9M	4.4M	4.2M
Long Term Debt Total	1.4M	1.8M	1.4M	892K	802.8K	1.3M
Property Plant Equipment	2.9M	3.5M	2.9M	2.4M	2.1M	2.0M
Other Liab	1.7M	365K	212K	966K	869.4K	1.0M
Net Tangible Assets	97.2M	31.9M	23.2M	14.7M	13.3M	12.6M
Deferred Long Term Liab	7.5M	8.7M	10.9M	4.9M	4.4M	8.7M
Capital Lease Obligations	1.8M	2.3M	1.9M	1.5M	3.3M	3.5M
Net Invested Capital	102.1M	36.8M	30.4M	23.2M	21.3M	20.3M
Short Long Term Debt	9.0M	14.9M	1.6M	1.4M	1.3M	1.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Nova Stock Analysis

When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC